Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1

被引:82
|
作者
Gorny, Miroslaw K. [1 ]
Wang, Xiao-Hong [3 ]
Williams, Constance [1 ]
Volsky, Barbara [1 ]
Revesz, Kathy [3 ]
Witover, Bradley [1 ]
Burda, Sherri [1 ]
Urbanski, Mateusz [1 ]
Nyambi, Phillipe [1 ,3 ]
Krachmarov, Chavdar [4 ]
Pinter, Abraham [4 ]
Zolla-Pazner, Susan [1 ,3 ]
Nadas, Arthur [2 ]
机构
[1] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA
[2] NYU, Sch Med, Inst Environm Med, New York, NY 10016 USA
[3] Vet Affairs New York Harbor Healthcare Syst, New York, NY 10010 USA
[4] Publ Hlth Res Inst, Newark, NJ 07103 USA
关键词
Immunoglobulin gene usage; Human monoclonal antibodies; Anti-HIV-1; antibodies; HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; EXTENSIVE SOMATIC MUTATION; POLYMERASE-CHAIN-REACTION; EQUATORIAL RAIN-FORESTS; MEMORY B-CELLS; MOLECULAR CHARACTERIZATION; TYPE-1; GP120; CORECEPTOR SELECTIVITY; ENVELOPE GLYCOPROTEIN;
D O I
10.1016/j.molimm.2008.09.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human anti-V3 monoclonal antibodies (mAbs) generated from HIV-1 infected individuals display diversity in the range of their cross-neutralization that may be related to their immunogenetic background. The study of the immunoglobulin (Ig) variable region gene usage of heavy chains have shown a preferential usage of the VH5-51 gene segment which was detected in 35% of 51 human anti-V3 mAbs. In contrast, human mAbs against other envelope regions of HIV-1 (anti-Env), including the CD4-binding domain, the CD4-induced epitope, and gp41 preferentially used the VH1-69 gene segment, and none of them used the VH5-51 gene, Furthermore, the usage of the VH4 family by anti-V3 mAbs was restricted to only one gene segment, VH4-59, while the VH3 gene family was used at a significantly lower frequency by all of the analyzed anti-HIV-1 mAbs. Multivariate analysis showed that usage of VH gene segments was significantly different between anti-V3 and anti-Env mAbs, and compared to antibodies from healthy subjects. In addition, the anti-V3 mAbs preferentially used the JH3 and D2-15 gene segments. The preferential usage of selected Ig gene segments and the characteristic pattern of Ig gene usage by anti-V3 mAbs can be related to the conserved structure of the V3 region. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:917 / 926
页数:10
相关论文
共 50 条
  • [31] Subtype-specific conservation of isoleucine 309 in the envelope V3 domain is linked to immune evasion in subtype C HIV-1 infection
    Lynch, Rebecca M.
    Rong, Rong
    Li, Bing
    Shen, Tongye
    Honnen, William
    Mulenga, Joseph
    Allen, Susan
    Pinter, Abraham
    Gnanakaran, S.
    Derdeyn, Cynthia A.
    VIROLOGY, 2010, 404 (01) : 59 - 70
  • [32] Crystal structure of a human rhinovirus that displays part of the HIV-1V3 loop and induces neutralizing antibodies against HIV-1
    Ding, JP
    Smith, AD
    Geisler, SC
    Ma, XJ
    Arnold, GF
    Arnold, E
    STRUCTURE, 2002, 10 (07) : 999 - 1011
  • [33] Human rhinovirus type 14 Human immunodeficiency virus type 1 (HIV-1) V3 loop chimeras from a combinatorial library induce potent neutralizing antibody responses against HIV-1
    Smith, AD
    Geisler, SC
    Chen, AA
    Resnick, DA
    Roy, BM
    Lewi, PJ
    Arnold, E
    Arnold, GF
    JOURNAL OF VIROLOGY, 1998, 72 (01) : 651 - 659
  • [34] A broad range of mutations in HIV-1 neutralizing human monoclonal antibodies specific for V2, V3, and the CD4 binding site
    Li, Liuzhe
    Wang, Xiao-Hong
    Williams, Constance
    Volsky, Barbara
    Steczko, Olivia
    Seaman, Michael S.
    Luthra, Kalpana
    Nyambi, Phillipe
    Nadas, Arthur
    Giudicelli, Veronique
    Lefranc, Marie-Paule
    Zolla-Pazner, Susan
    Gorny, Miroslaw K.
    MOLECULAR IMMUNOLOGY, 2015, 66 (02) : 364 - 374
  • [35] PATTERN OF ANTIBODY-RESPONSE AGAINST THE V3 LOOP IN CHILDREN WITH VERTICALLY ACQUIRED IMMUNODEFICIENCY VIRUS TYPE-1 (HIV-1) INFECTION
    DEROSSI, A
    ZANOTTO, C
    MAMMANO, F
    OMETTO, L
    DELMISTRO, A
    CHIECOBIANCHI, L
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (03) : 221 - 228
  • [36] Association of mutations in V3/C3 domain with enhanced sensitivity of HIV-1 clade C primary envelopes to autologous broadly neutralizing plasma antibodies
    Suprit Deshpande
    Shilpa Patil
    Rajesh Kumar
    Tripti Shrivastava
    Aylur K. Srikrishnan
    Kailapuri G. Murugavel
    Wayne C. Koff
    Bimal K. Chakrabarti
    Jayanta Bhattacharya
    Retrovirology, 13
  • [37] Association of mutations in V3/C3 domain with enhanced sensitivity of HIV-1 clade C primary envelopes to autologous broadly neutralizing plasma antibodies
    Deshpande, Suprit
    Patil, Shilpa
    Kumar, Rajesh
    Shrivastava, Tripti
    Srikrishnan, Aylur K.
    Murugavel, Kailapuri G.
    Koff, Wayne C.
    Chakrabarti, Bimal K.
    Bhattacharya, Jayanta
    RETROVIROLOGY, 2016, 13
  • [38] Broadly reactive antibodies against a gp120 V3 loop multi-epitope polypeptide neutralize different isolates of human immunodeficiency virus type 1 (HIV-1)
    Montero, M
    Menendez, A
    Dominguez, MD
    Navea, L
    Vilarubia, OL
    Quintana, D
    Izquierdo, M
    Jimenez, V
    Reyes, O
    Lobaina, L
    Noa, E
    Duarte, CA
    VACCINE, 1997, 15 (11) : 1200 - 1208
  • [39] Tropism, coreceptor use, and phylogenetic analysis of both the V3 loop and the protease gene of three novel HIV-1 group O isolates
    Vallejo, A
    Heredia, A
    Mas, A
    Lee, SF
    Epstein, JS
    Soriano, V
    Hewlett, IK
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1998, 18 (05) : 417 - 425
  • [40] The V3-directed immune response in natural human immunodeficiency virus type 1 infection is predominantly directed against a variable, discontinuous epitope presented by the gp120 V3 domain
    Schreiber, M
    Wachsmuth, C
    Muller, H
    Odemuyiwa, S
    Schmitz, H
    Meyer, S
    Meyer, B
    SchneiderMergener, J
    JOURNAL OF VIROLOGY, 1997, 71 (12) : 9198 - 9205